Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 February 2017
|
| In: |
Chemical biology and drug design
Year: 2017, Jahrgang: 90, Heft: 3, Pages: 352-367 |
| ISSN: | 1747-0285 |
| DOI: | 10.1111/cbdd.12966 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1111/cbdd.12966
|
| Verfasserangaben: | Nikolaos Lougiakis, Efseveia Frakolaki, Panagiota Karmou, Nicole Pouli, Panagiotis Marakos, Vanesa Madan, Ralf Bartenschlager, Niki Vassilaki |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572523654 | ||
| 003 | DE-627 | ||
| 005 | 20230426124309.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180502s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/cbdd.12966 |2 doi | |
| 035 | |a (DE-627)1572523654 | ||
| 035 | |a (DE-576)502523654 | ||
| 035 | |a (DE-599)BSZ502523654 | ||
| 035 | |a (OCoLC)1341008071 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lougiakis, Nikolaos |e VerfasserIn |0 (DE-588)1161041826 |0 (DE-627)1024450848 |0 (DE-576)506329356 |4 aut | |
| 245 | 1 | 0 | |a Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism |c Nikolaos Lougiakis, Efseveia Frakolaki, Panagiota Karmou, Nicole Pouli, Panagiotis Marakos, Vanesa Madan, Ralf Bartenschlager, Niki Vassilaki |
| 264 | 1 | |c 28 February 2017 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.05.2018 | ||
| 700 | 1 | |a Madan Renes, Vanesa |e VerfasserIn |0 (DE-588)1060272296 |0 (DE-627)799360341 |0 (DE-576)416362516 |4 aut | |
| 700 | 1 | |a Bartenschlager, Ralf |d 1958- |e VerfasserIn |0 (DE-588)1058097989 |0 (DE-627)796390509 |0 (DE-576)168706067 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemical biology and drug design |d Oxford : Wiley-Blackwell, 2006 |g 90(2017), 3, Seite 352-367 |h Online-Ressource |w (DE-627)505951037 |w (DE-600)2216600-2 |w (DE-576)252074947 |x 1747-0285 |7 nnas |a Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism |
| 773 | 1 | 8 | |g volume:90 |g year:2017 |g number:3 |g pages:352-367 |g extent:16 |a Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism |
| 856 | 4 | 0 | |u https://doi.org/10.1111/cbdd.12966 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180502 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1058097989 |a Bartenschlager, Ralf |m 1058097989:Bartenschlager, Ralf |d 910000 |d 911700 |d 700000 |d 718000 |e 910000PB1058097989 |e 911700PB1058097989 |e 700000PB1058097989 |e 718000PB1058097989 |k 0/910000/ |k 1/910000/911700/ |k 0/700000/ |k 1/700000/718000/ |p 7 | ||
| 998 | |g 1060272296 |a Madan Renes, Vanesa |m 1060272296:Madan Renes, Vanesa |d 910000 |d 911700 |e 910000PM1060272296 |e 911700PM1060272296 |k 0/910000/ |k 1/910000/911700/ |p 6 | ||
| 999 | |a KXP-PPN1572523654 |e 3007752507 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"16 S."}],"note":["Gesehen am 02.05.2018"],"person":[{"given":"Nikolaos","role":"aut","display":"Lougiakis, Nikolaos","family":"Lougiakis","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Madan Renes","display":"Madan Renes, Vanesa","role":"aut","given":"Vanesa"},{"display":"Bartenschlager, Ralf","role":"aut","given":"Ralf","roleDisplay":"VerfasserIn","family":"Bartenschlager"}],"origin":[{"dateIssuedDisp":"28 February 2017","dateIssuedKey":"2017"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 02.12.10"],"origin":[{"publisherPlace":"Oxford ; Oxford","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"Wiley-Blackwell ; Blackwell Publ. [[-2008]]"}],"id":{"zdb":["2216600-2"],"issn":["1747-0285"],"doi":["10.1111/(ISSN)1747-0285"],"eki":["505951037"]},"recId":"505951037","disp":"Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanismChemical biology and drug design","title":[{"title_sort":"Chemical biology and drug design","title":"Chemical biology and drug design"}],"part":{"text":"90(2017), 3, Seite 352-367","pages":"352-367","year":"2017","volume":"90","issue":"3","extent":"16"},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["67.2006 -"]}],"id":{"doi":["10.1111/cbdd.12966"],"eki":["1572523654"]},"recId":"1572523654","title":[{"title":"Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism","title_sort":"Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism"}],"name":{"displayForm":["Nikolaos Lougiakis, Efseveia Frakolaki, Panagiota Karmou, Nicole Pouli, Panagiotis Marakos, Vanesa Madan, Ralf Bartenschlager, Niki Vassilaki"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"]} | ||
| SRT | |a LOUGIAKISNNOVELNUCLE2820 | ||